The RNA analysis/transcriptomics market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period. The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding for omics, and the increasing applications of RNA sequencing in the transcriptomics market. The increasing focus on biomarker discovery and toxicogenomics, along with the increasing interest in outsourcing services, is expected to offer significant growth opportunities for the players operating in the global RNA analysis/transcriptomics market. On the other hand, the requirement of high capital investments and data management issues are expected to restrain the growth of this market to a certain extent.
Based on product, the reagents/consumables segment holds the largest market share during the forecast period. Based on product & service, the RNA analysis/Transcriptomics market is segmented into reagents/consumables, instruments, software, and services.The reagents/consumables segment accounted for the larger market share in 2019.
The increasing demand for high-quality reagents and the repeated use of media and reagents in transcriptome studies. Additionally, the growing R&D activities in the pharmaceutical industry, growing government investments in the field of life science research, and the increasing research being undertaken with integrated omics studies are contributing to the market for consumables.
Based on technology, the sequencing technologies segment is expected to register the highest CAGR during the forecast period. Based on technology, the RNA analysis/transcriptomics market is segmented into microarrays, PCR, sequencing technologies (Sanger sequencing and NGS technologies), and RNAi (gene silencing).The sequencing technologies segment is expected to witness the highest growth during the forecast period.
RNA sequencing allows direct access to sequences of mRNA and is an equitable technology, which makes it more suitable for target identification and drug discovery applications.RNA sequencing also helps to overcome several issues associated with microarrays, such as bias and variation due to hybridization and labeling efficiencies.
Technological advancements in this segment are further set to drive market growth.
The drug discovery segment is expected to account for the largest share of the RNA analysis/transcriptomics market in 2019 The drug discovery segment accounted for the largest share of the market in 2019.This is attributed to the use of transcriptomics in drug discovery for target identification and validation, identification of efficacy and toxicity biomarkers from biological fluids, and investigation of drug action and toxicity mechanisms.
The growing need to study a large number of genes to gain a better understanding of gene-to-drug interactions is further expected to drive the use of transcriptomic technologies in drug discovery applications.
CROs end user segment is expected to grow at the highest CAGR in the RNA analysis/transcriptomics market during the forecast period Based on end user, the RNA analysis/transcriptomics market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & diagnostic centers, and contract research organizations.The contract research organizations (CROs) segment is expected to witness the highest growth during the forecast period.
CROs provide affordable outlets for companies and academia to pursue new medicines and offer a cost-effective solution to developing drugs.They also support foundations, research institutions, and universities, in addition to government organizations, such as the NIH and EMA.
These factors are driving the growth of this segment.
North America is expected to account for the largest share of the RNA analysis/transcriptomics market in 2019 In 2019, North America accounted for the largest share of the RNA analysis/transcriptomics market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa.The large share of this market segment can be attributed to the increasing development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, high life science research funding, high biopharmaceutical R&D expenditure, and the greater adoption of advanced technologies in North America.
The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment.
Break of primary participants was as mentioned below: • By Company Type – Tier 1–35%, Tier 2–5%, and Tier 3–20% • By Designation – C-level–35%, Director-level–25%, Others–40% • By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%
Key players in the RNA analysis/transcriptomics market The key players operating in the RNA analysis/transcriptomics market include Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Fluidigm Corporation (US), Eurofins Scientific (Germany), Sequentia Biotech SL (Spain), Acobiom (France), GenXPro GmbH (Germany), CD Genomics (US), Promega Corporation (US), Lexogen GmbH (Austria), Cenix BioScience GmbH (Germany), Takara Holdings, Inc. (Japan), bioMérieux SA (France), and LC Sciences LLC (US).
Research Coverage: The report analyzes the RNA analysis/transcriptomics market and aims at estimating the market size and future growth potential of this market based on various segments such as product, technology, application, end user, and region.The report also includes a product portfolio matrix of various RNA analysis/transcriptomics products available in the market.
The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers: • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global RNA analysis/transcriptomics market. The report analyzes this market by product, technology, application, and end user • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global RNA analysis/transcriptomics market • Market Development: Comprehensive information on the lucrative emerging markets by product, technology, application, and end user • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global RNA analysis/transcriptomics market • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global RNA analysis/transcriptomics market.
Our reports have been used by over 10K customers, including:
G-protein coupled receptors market is anticipated to be driven by rising number of cancer cases, rising prevalence of lifestyle-related issues, such as cardiovascular infections, and respiratory issues. G-protein coupled receptors (GPCRs) are exceptionally helpful in the innovative work of newer medication substances. Furthermore, the increasing...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global dPCR and qPCR Market Report The dPCR and qPCR market by revenue is expected to grow at a CAGR of over 9% during the period 2020–2025. The global digital PCR (dPCR) and the real-time PCR (qPCR) market is one of the dynamic and fast-growing...
Immunochemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Immunochemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Immunochemistry Rapid Tests & POC pipeline products...
Inborn Gene or Chromosome Alterations Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Inborn Gene or Chromosome Alterations Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Inborn Gene or Chromosome Alterations...
Retrovirus Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Retrovirus Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Retrovirus Rapid Tests & POC pipeline products with comparative...
224 pages •
By The Business Research Company
• Dec 2020
Next Generation Sequencing Global Market Opportunities And Strategies 2020-30: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global next generation sequencing market. Description: Where is the largest and fastest growing...
Parasitology and Mycology Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Parasitology and Mycology Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Parasitology & Mycology Tests pipeline products with comparative...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.